Merck discounts Januvia for Indian market; FDA sets hearing on social media;

> Merck's subsidiary in India launched its diabetes drug Januvia at one-fifth the U.S. price, establishing a strategy of high-volume, low-margin sales for that market, local executives said. Report

> The FDA set a public hearing on using the internet and social media to promote drugs as a step toward possible marketing guidelines. Report

> One of Britain's leading bone specialists is facing disciplinary action over accusations that he was involved in "ghost writing" a journal article. Report

> Bayer's and Onyx Pharmaceuticals' drug Nexavar helped stave off progression of breast tumors, the most common form of cancer in women, a study found. Report

> At a time when global multinational drug makers are slashing their workforces to reduce costs, their Indian counterparts are on a hiring spree. Report

> Sanofi-Aventis chief Chris Viehbacher said its first H1N1 vaccine doses would be delivered to the U.S. in mid-October and in France by the end of November. Report

> Celgene shares could rebound on increased use of the cancer drug Revlimid, said a Robert W. Baird analyst who upgraded the stock. Report

Biotech News

> Biogen Idec won't take no as an answer to its buyout proposal for development partner Facet Biotech. Article

> Nektar Therapeutics will pocket $125 million upfront and up to $1.4 billion in milestones in exchange for licensing two of its therapies for pain and opioid-induced constipation. Article

> Amgen shares got a boost this morning as researchers for the company continued to build a blockbuster case for their bone drug denosumab. Article

Biotech IT News

> Phase Forward has contracted BMC Software to manage virtual machines in a datacenter running applications that support hosted clinical trials and data capture and management. Article

> The 2009 Edition of the DDI Predict software application targets risk assessment of drug-drug interactions, including those involving multiple enzymatic pathways. Recent DDIs have caused adverse events leading to removal of drugs from the market, says Paris-based Aureus Pharma. Article

> Genedata has unveiled Expressionist 5.3, which emphasizes capabilities for transcriptomics-based biomarker discovery for drug profiling and patient selection. Article

And Finally... A daily dose of aspirin can prevent cancer in people with a genetic disorder that increases their risk of developing the disease. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.